Brief: Paxman Secures First Uk Orders For Neuropathy System
30/10/2026 11:03
BRIEF-Paxman Secures First Uk Orders For Neuropathy System Oct 30 (Reuters) - Paxman AB (publ) PAX.ST:
PAXMAN SECURES FIRST UK ORDERS FOR NEUROPATHY SYSTEM AHEAD OF COMMERCIAL LAUNCH TO ADDRESS THE SIGNIFICANT UNMET CLINICAL NEED OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY (CIPN)
Source text: ID:nMFNZGwW8
Further company coverage: PAX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Paxman AB (publ)
See all newsBrief: Paxman Secures First Uk Orders For Neuropathy System
Sweden's Paxman Q2 revenue rises 40% as net income turns positive
Brief: Paxman Reports Q2 Group Revenue Of SEK 105 Million
Brief: Paxman Says CMS Releases Cy2027 Proposed OPPS, MPFS Rules For Mechanical Scalp Cooling
Sweden's Paxman Q1 revenue rises 34% on Dignitana acquisition